๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2025-08-19

GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial (NCT06141135)

๐ŸŸข Recruiting Observational / Diagnostic ๐Ÿ“‹ Clinical Research Protocol Sponsor: Genomic Prediction Inc.

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

Who can join: Review the eligibility criteria below.

Location: Boston IVF โ€” Waltham, Massachusetts

Age range: 35 Years to 40 Years

๐Ÿงช Interventions in This Study

  • Preimplantation genetic testing for aneuploidy (PGTA) (OTHER)

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • Boston IVF โ€” Waltham, Massachusetts

๐Ÿ“ž Contact the Study Coordinator

Phone: (973) 529-4223

Email: talia@genomicprediction.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—